Abstract
Background Clinicians and travelers often have limited tools to differentiate bacterial from non-bacterial causes of travelers’ diarrhea (TD). Development of a clinical prediction rule assessing the etiology of TD may help identify episodes of bacterial diarrhea and limit inappropriate antibiotic use. We aimed to identify predictors of bacterial diarrhea among clinical, demographic, and weather variables, as well as to develop and cross-validate a parsimonious predictive model.
Methods We collected de-identified clinical data from 457 international travelers with acute diarrhea presenting to two healthcare centers in Nepal and Thailand. We used conventional microbiologic and multiplex molecular methods to identify diarrheal etiology from stool samples. We used random forest and logistic regression to determine predictors of bacterial diarrhea.
Results We identified 195 cases of bacterial etiology, 63 viral, 125 mixed pathogens, 6 protozoal/parasite, and 68 cases without a detected pathogen. Random forest regression indicated that the strongest predictors of bacterial over viral or non-detected etiologies were average location-specific environmental temperature and RBC on stool microscopy. In 5-fold cross-validation, the parsimonious model with the highest discriminative performance had an AUC of 0.73 using 3 variables with calibration intercept -0.01 (SD 0.31) and slope 0.95 (SD 0.36).
Conclusions We identified environmental temperature, a location-specific parameter, as an important predictor of bacterial TD, among traditional patient-specific parameters predictive of etiology. Future work includes further validation and the development of a clinical decision-support tool to inform appropriate use of antibiotics in TD.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported in part by the NIAID of the NIH under award number R01AI135114 (to D.T.L.), and by the University of Utah Study Design and Biostatistics Center, with funding in part from the National Center for Research Resources and the National Center for Advancing Translational Sciences, and National Institutes of Health.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The institutional review boards of the University of Utah, the Walter Reed Army Institute of Research, CIWEC Hospital, the Nepal Health Research Council (NHRC), and Bumrungrad International Hospital, gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Financial Support This work was supported in part by the NIAID of the NIH under award number R01AI135114 (to D.T.L.), and by the University of Utah Study Design and Biostatistics Center, with funding in part from the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant UL1TR002538 (formerly 5UL1TR001067-05, 8UL1TR000105 and UL1RR025764).
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
